Brie Carter

Vistagen (NASDAQ:VTGN) announced disappointing results from its PALISADE-3 Phase 3 clinical trial of intranasal fasedienol, a treatment for social anxiety disorder.

The study failed to meet its primary endpoint, which was based on the change from baseline in the Subjective Units of Distress Scale (SUDS).

Dyadic (NASDAQ:DYAI) has expanded its strategic collaboration with Fermbox Bio to enhance the manufacturing, commercialization, and dual-sourcing of animal-free proteins and enzymes developed by Dyadic.

Steel Dynamics (NASDAQ:STLD) has provided its earnings guidance for the fourth quarter of fiscal year 2025, forecasting a range of $1.65 to $1.69 per diluted share.

This represents a notable decline from the $2.74 per share earnings reported in the third quarter of 2025, but an increase over the $1.36 per share reported in Q4 2024.

China Automotive Systems (NASDAQ:CAAS) announced that its subsidiary, Hubei Henglong, has won a contract to supply its column-assist electric power steering (C-EPS) system for a new South American vehicle platform.

Diageo (NYSE:DEO) has reached an agreement to sell its 65% stake in East African Breweries (EABL) and its 53.68% share in UDVK to Japan’s Asahi Group for an estimated net gain of $2.3 billion after taxes and transaction costs.

US Senator Elizabeth Warren is pressing US authorities to disclose whether DeFi platforms like PancakeSwap are under investigation as crypto market structure legislation faces delays.

Visa has launched USDC settlement for selected US banks on the Solana blockchain, signalling a broader push to modernise payments as stablecoin adoption grows.

Bank of Canada lays out criteria for ‘good money’ stablecoins

Canada’s central bank is setting strict standards for stablecoins, signalling that only fully fiat-backed, high-quality tokens will qualify as “good money” under future regulations. Governor Tiff Macklem says the approach aims to balance innovation with safety as Canada modernises its financial system ahead of planned stablecoin rules in 2026.

HEICO Corporation (NYSE:HEI) announced that its Flight Support Group subsidiary, Wencor, has entered into an agreement to acquire EthosEnergy Accessories and Components, a leading provider of repair services for aeroderivative gas turbine engine accessories.

Cosette Pharmaceuticals said the U.S. Food and Drug Administration has approved its abbreviated new drug application for the first generic version of CIPRO HC, granting the company 180 days of Competitive Generic Therapy exclusivity and ending a more than 27-year stretch without a generic alternative.